2022
DOI: 10.5530/ajphs.2021.11.27
|View full text |Cite
|
Sign up to set email alerts
|

Dermatomyositis Flare Up: A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Anti-TIFI and anti-NXP2 are associated with an increased risk of cancer. On the other hand, anti-Mi2 antibodies are associated with a benign form of dermatomyositis and have favorable treatment [7,8].…”
Section: Discussionmentioning
confidence: 99%
“…Anti-TIFI and anti-NXP2 are associated with an increased risk of cancer. On the other hand, anti-Mi2 antibodies are associated with a benign form of dermatomyositis and have favorable treatment [7,8].…”
Section: Discussionmentioning
confidence: 99%